...
首页> 外文期刊>Glia >Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis
【24h】

Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis

机译:微管蛋白聚合促进蛋白(TPPP / p25)作为多发性硬化症少突胶质细胞改变的标志

获取原文
获取原文并翻译 | 示例

摘要

Multiple sclerosis (MS) is an idiopathic chronic inflammatory demyelinating disease of the central nervous system with variable extent of remyelination. Remyelination originates from oligodendrocyte (OG) precursor cells, which migrate and differentiate into mature OG. Tubulin polymerization promoting protein (TPPP/p25) is located in mature OG and aggregates in oligodendroglial cytoplasmic inclusions in multiple system atrophy. We developed a novel monoclonal anti-TPPP/p25 antibody to quantify OG in different subtypes and disease stages of MS, and possible degenerative changes in OG. We evaluated autopsy material from 25 MS cases, including acute, primary progressive, secondary progressive, relapsing remitting MS, and five controls. Demyelinated lesions revealed loss of TPPP/p25-positive OG within the plaques. In remyelination, TPPP/p25 was first expressed in OG cytoplasms and later became positive in myelin sheaths. We observed increased numbers of TPPP/ p25 immunoreactive OG in the normal appearing white matter (NAWM) in MS patients. In MS cases, the cytoplasmic area of TPPP/p25 immunoreactivity in the OG was higher in the periplaque area when compared with NAWM and the plaque, and TPPP/p25 immunoreactive OG cytoplasmic area inversely correlated with the disease duration. There was a lack of phospho-TDP-43, phospho-tau, a-synuclein, and ubiquitin immunoreactivity in OG with enlarged cytoplasm. Our data suggest impaired differentiation, migration, and activation capacity of OG in later disease stages of MS. Upregulation of TPPP/p25 in the periplaque white matter OG without evidence for inclusion body formation might reflect an activation state. Distinct and increased expression of TPPP/p25 in MS renders it a potential prognostic and diagnostic marker of MS.
机译:多发性硬化症(MS)是中枢神经系统的特发性慢性炎症性脱髓鞘疾病,具有不同程度的髓鞘再生。髓鞘再生起源于少突胶质细胞(OG)前体细胞,其迁移并分化为成熟的OG。微管蛋白聚合促进蛋白(TPPP / p25)位于成熟的OG中,并在多系统萎缩中聚集在少突胶质细胞质包裹体中。我们开发了一种新型的抗TPPP / p25单克隆抗体,用于定量分析MS不同亚型和疾病阶段的OG,以及OG可能的退化性变化。我们评估了25例MS患者的尸检材料,包括急性,原发进行性,继发进行性,复发缓解型MS和五个对照。脱髓鞘的病变显示斑块内TPPP / p25阳性OG丢失。在髓鞘再生中,TPPP / p25首先在OG细胞质中表达,随后在髓鞘中呈阳性。我们观察到MS患者正常出现的白质(NAWM)中TPPP / p25免疫反应性OG数量增加。在MS病例中,与NAWM和噬斑相比,OG中的TPPP / p25免疫反应性的细胞质区域在斑块周围区域较高,并且TPPP / p25免疫反应性OG的胞质区域与疾病持续时间呈负相关。 OG胞浆扩大时,缺乏磷酸化TDP-43,磷酸化tau,α-突触核蛋白和泛素免疫反应性。我们的数据表明,在MS的晚期疾病中,OG的分化,迁移和激活能力受损。斑块周围白质OG中TPPP / p25的上调,没有包涵体形成的证据,可能反映了激活状态。 TPPP / p25在MS中的独特表达和增加使其成为MS的潜在预后和诊断标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号